MediciNova, Inc.
MNOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1,000 | $0 | $4,037 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1,000 | $0 | $4,037 |
| % Margin | – | 100% | – | 100% |
| R&D Expenses | $7,195 | $5,658 | $9,143 | $8,100 |
| G&A Expenses | $5,222 | $4,984 | $5,236 | $5,487 |
| SG&A Expenses | $5,481 | $5,242 | $5,485 | $5,715 |
| Sales & Mktg Exp. | $259 | $258 | $249 | $229 |
| Other Operating Expenses | -$0 | -$0 | $0 | $438 |
| Operating Expenses | $12,675 | $10,900 | $14,629 | $14,253 |
| Operating Income | -$12,675 | -$9,900 | -$14,629 | -$10,216 |
| % Margin | – | -990% | – | -253% |
| Other Income/Exp. Net | $1,631 | $1,332 | $562 | $84 |
| Pre-Tax Income | -$11,044 | -$8,568 | -$14,066 | -$10,132 |
| Tax Expense | $6 | $3 | $3 | $3 |
| Net Income | -$11,050 | -$8,572 | -$14,069 | -$10,134 |
| % Margin | – | -857.2% | – | -251% |
| EPS | -0.23 | -0.17 | -0.29 | -0.21 |
| % Growth | -35.3% | 41.4% | -38.1% | – |
| EPS Diluted | -0.23 | -0.17 | -0.29 | -0.21 |
| Weighted Avg Shares Out | 49,046 | 49,046 | 49,045 | 48,596 |
| Weighted Avg Shares Out Dil | 49,046 | 49,046 | 49,045 | 48,596 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,671 | $1,835 | $810 | $144 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $21 | $20 | $18 | $26 |
| EBITDA | -$12,654 | -$9,880 | -$14,611 | -$10,190 |
| % Margin | – | -988% | – | -252.4% |